Literature DB >> 1815961

Pentoxifylline in arterial disease of the legs.

R Verhaeghe, M Verstraete.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1815961     DOI: 10.1007/BF00314975

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  22 in total

1.  Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group.

Authors:  F Lindgärde; R Jelnes; H Björkman; G Adielsson; T Kjellström; I Palmquist; L Stavenow
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

2.  Effect of daily muscular exercise in patients with intermittent claudication.

Authors:  O A Larsen; N A Lassen
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

3.  Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.

Authors:  H A Cameron; P C Waller; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

4.  The measured effect of stopping smoking on intermittent claudication.

Authors:  C R Quick; L T Cotton
Journal:  Br J Surg       Date:  1982-06       Impact factor: 6.939

5.  Impaired red cell deformability in peripheral vascular disease.

Authors:  H L Reid; J A Dormandy; A J Barnes; P J Lock; T L Dormandy
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

6.  Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial.

Authors:  T S Creasy; P J McMillan; E W Fletcher; J Collin; P J Morris
Journal:  Eur J Vasc Surg       Date:  1990-04

7.  Blood flow properties and walking performance in chronic arterial occlusive disease.

Authors:  B Angelkort; P Spürk; A Habbaba; M Mähder
Journal:  Angiology       Date:  1985-05       Impact factor: 3.619

8.  Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication.

Authors:  J A Dormandy; E Hoare; J Colley; D E Arrowsmith; T L Dormandy
Journal:  Br Med J       Date:  1973-12-08

9.  Treatment of claudication with pentoxifylline: are benefits related to improvement in viscosity?

Authors:  W C Johnson; J M Sentissi; D Baldwin; J Hamilton; J Dion
Journal:  J Vasc Surg       Date:  1987-09       Impact factor: 4.268

10.  The effect of pentoxifylline on the flow properties of human blood.

Authors:  A M Ehrly
Journal:  Curr Med Res Opin       Date:  1978       Impact factor: 2.580

View more
  1 in total

Review 1.  Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.

Authors:  J E Frampton; R N Brogden
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.